The role of prostaglandins in the control of aldosterone production was studied in isolated rat glomerulosa cells. Exogenous prostaglandin E2 in concentrations above 10\m=-\9 mol/l increased the production rate of aldosterone; this effect was attenuated by the competitive antagonist, 7-oxa-13-prostynoic acid. Prostaglandin F2\g=a\(10\m=-\9\p=n-\10\m=-\5mol /l ) failed to influence the production rate of aldosterone. The aldosterone-stimulating effect of the prostaglandin precursor, arachidonic acid (5 \ m=x\10\m=-\4mol/l), could not be blocked by inhibitors of prostaglandin synthesis. Basal production rate of aldosterone was not significantly influenced by non-steroidal anti-inflammatory drugs. Glomerulosa cells were stimulated by angiotensin II; this effect was not potentiated by arachidonic acid and was reduced only slightly by indomethacin. The cells were also stimulated by corticotrophin and potassium ions. The effect of these substances was not potentiated by arachidonic acid and was not inhibited by non-steroidal anti-inflammatory drugs. These results do not confirm the presumption that intra-adrenal prostaglandins play an essential role in the control of aldosterone secretion. Some effects of arachidonic acid and its antagonist, eicosatetraynoic acid, on aldosterone production are considered to be independent of changes in prostaglandin synthesis.
INTRODUCTION
The effect of prostaglandins on steroid secretion has been under examination for several years, but the role of intra-adrenal prostaglandins in the control of aldosterone secretion is far from being established. The metabolism of prostaglandins in the adrenal zona glomerulosa has not been systematically studied, until now the synthesis of only two primary prostaglandins, prostaglandin (PG) E2 and PGF2" having been demonstrated (Campbell, Gomez-Sanchez, Adams, Schmitz & Itskovitz, 1979; Matsuoka, Tan & Mulrow, 1980; Miller, Douglas & Dunn, 1980) . Prostaglandin E2 has been found to increase the production rate of aldosterone by incubated rat (Spät, Sarkadi, Intödy, Körner & Szántó, 1971; Spät & Józan, 1975; Campbell, Gomez-Sanchez & Adams, 1980) , bovine (Saruta & Kaplan, 1972) and human (Honn & Chavin, 1976) adrenal tissue or cells but was without effect when infused into the adrenal artery of the sheep (Blair-West, Coghlan, Dentón, Funder, Scoggins & Wright, 1971) . Reports on the effect of PGF2s are conflicting (Saruta & Kaplan, 1972; Honn & Chavin, 1976;  Spät, Antoni, Balla, Bontà & Siklós, 1977) . Prostaglandin A2 exerts a stimulatory action on incubated rat glomerulosa tissue (Spät & Józan, 1975) and PGA, has a dose-dependent effect on incubated diced human adrenal (Honn & Chavin, 1977) . The physiological relevance of these data, however, is rather doubtful as circulating or intraadrenal PGA has not been demonstrated. The endoperoxide PGH2 failed to alter aldosterone production by rat glomerulosa cells (Campbell et al. 1980 ) and data are not available concerning the effects of prostacyclin on the synthesis of aldosterone.
Altered production rate of a prostaglandin in response to angiotensin II, potassium ion or corticotrophin (ACTH) , the known physiological stimulators of aldosterone secretion, would accord with the presumption of the physiological role of prostaglandins in the control of the function of glomerulosa cells. No change in the release of PGE2 or PGF27 by isolated glomerulosa cells in response to angiotensin II and III (Campbell et al. 1980; Miller et al. 1980) or potassium ion (Miller et al. 1980 ) has been demonstrated. Increased PGE2 content in glomerulosa cells after stimulation with ACTH has been found in one experiment by Matsuoka et al. (1980) , but no change was observed by Miller et al. (1980) .
Another approach to assess the role of intracellular prostaglandins is to monitor the interaction between inhibitors of prostaglandin synthesis and the known stimulators of aldosterone secretion. Since the few published data (detailed in the Discussion) are also conflicting, we have systematically examined the effect of PGE2, PGF2a, the prostaglandin precursor, arachidonic acid, and that of several inhibitors of prostaglandin synthesis on basal and stimulated aldosterone production by isolated rat glomerulosa cells. The results presented in this paper do not confirm the physiological significance of intra-adrenal prostaglandins in the control of aldosterone secretion.
MATERIALS AND METHODS

Materials
Deoxyribonuclease (DNAse, (Spät, Siklós, Antoni, Nagy & Szirányi, 1977) .
Preparation and incubation of isolated glomerulosa cells The glomerulosa cell suspension was prepared using a modification of the method described by Fredlund, Saltman & Catt (1975 (Brownlee, 1961) or paired-sample /-test.
RESULTS
Effect of PGE2, PGF2ct, arachidonic acid and prostaglandin inhibitors on basal aldosterone production Exogenous PGE2 in concentrations above 10~9 mol/1 stimulated aldosterone production ( Fig. 1 ). 7-Oxa-13-prostynoic acid ( 10 " 4 mol/1), the competitive antagonist of PGE2, reduced the effect of PGE2. The antagonist inhibited the response to 10"7 mol PGE2/1 by 64-5 ±2-8 (s.e.m.) % (n = 3 duplicates) and that to 3 10"7 mol PGE2/1 by 34-3 or 26-0% (n = 2 duplicates). The aldosterone production rate in the presence of the highest concentration (10~6mol/1) of PGE, examined was not significantly influenced by the antagonist (n = 3 duplicates). Prostaglandin F2a, (10~9-10~5mol/1) failed to influence the production rate of aldosterone ( Fig. 1) .
Arachidonic acid at a concentration of 5 10~6 and 10~4 mol/1 did not affect basal aldo¬ sterone output (n = 3 duplicates) while 5xl0-4 mol arachidonic acid/1 induced a 3-29 ± 0-38 -fold increase in the production rate of the hormone (n = 7 duplicates). The nonsteroidal anti-inflammatory drugs, indomethacin (3 10"5 mol/1) and niflumic acid (10-4 mol/1), failed to abolish the stimulatory effect of arachidonic acid. Fig. 3a . The minimal effective concentration was 2-5 10" 10mol/l (P< 0-001, = 7), and the maximal response was attained by 2-5 IO"8 mol/1. Indomethacin reduced angiotensin-induced aldosterone production to 88-6 + 2-1% (n modified by indomethacin at all (data not shown). As is shown in Fig. 3a , ETY (10"4 mol/1) had no effect on aldosterone production rate. In one experiment glomerulosa cells were isolated from indomethacin-pretreated rats, the drug also being added to the medium throughout the preparative and incubation procedures. The response to angiotensin II did not differ from that of control cells (data not shown).
The lowest concentration of ACTH which significantly stimulated the production rate of aldosterone was 3x10" 10 mol/1 ( <0·02, = 7). The effect of ACTH was not modified by indomethacin (Fig. 3b) , but the response to high concentrations of ACTH was reduced by ETY (P<0-05 at 3 10"8mol ACTH/1 and P<0001 at 3 10"7mol ACTH/1) (Fig. 36) . Several other inhibitors of prostaglandin synthesis (niflumic acid, carprofen, meclofenamic acid) and the PGE2 antagonist, 7-oxa-13-prostynoic acid (each at 10"4mol/1, n -2 duplicates), did not influence the action of 3 IO"7 mol ACTH/1 on aldosterone production (Fig. 4a ). Due to a considerable variation between the responsiveness of control cells to potassium, the conventional presentation of the dose-response curves has masked the effect of ETY (Fig. 4b) . It was, however, observed that the effect of ETY depended on the size of the response to potassium. When hormone production was moderately increased, ETY further enhanced the response, while ETY appeared to be inhibitory when steroid production was greatly stimulated by potassium (Fig. 4c) (Campbell et al. 1979 (Campbell et al. ,1980 Matsuoka et al. 1980; Miller et al. 1980) in this respect may reflect differences in basal prostaglandin production or in the sensitivity of the isolated cells to non-specific effects of these drugs. The significant augmentation of basal aldosterone production rate by ETY resembles the effect of its counterpart, arachidonic acid, and may be attributed to a non¬ specific effect of this lipid derivative.
In order to evalute the mediating or modulating role of prostaglandins in the stimulation of aldosterone production by angiotensin II, potassium ion or ACTH, we have examined the effect of several inhibitors of prostaglandin synthesis on aldosterone production in combination with these substances. Because of the lack of determination of prostaglandins we cannot judge whether there was any significant increase in the production of prostaglandins in response to the agonists applied. Nevertheless, even if the cells were incapable of prostaglandin synthesis, the appropriate increases in aldosterone production upon the addition of its physiological stimulators would imply that production of intracellular prostaglandins is not a prerequisite of a maintained aldosterone production. (Campbell et al. 1979 ). In our previous experiments (Spät, 1979) indomethacin reduced both the basal and angiotensin-induced production of aldosterone by rat glomerulosa cells, which were isolated using the method of Haning, Tait & Tait (1970 ) it was found that indomethacin completely blocked the furosemide-induced, angiotensin-mediated hyper¬ aldosteronism in dexamethasone-pretreated conscious rats while plasma renin activity was still an order of magnitude higher than the control level. It was therefore suggested that indomethacin might interfere with the aldosterone-stimulating action of angiotensin at some adrenal site. However, on the basis of the data presented here, an extra-adrenal site of action of indomethacin seems more likely.
Despite several reports on the stimulatory effect of prostaglandins on steroid production by the adrenal zona fasciculata-zona reticularis (cf. Duperray & Chambaz, 1980a) , the role of these substances in mediating or modulating the action of ACTH has not been sufficiently elucidated. Enhanced (Laychock & Rubin, 1975 Vahouny, Chanderbhan, Hinds, Hodges & Treadwell, 1978) , unchanged (Duperray & Chambaz, 19806; Matsuoka et al. 1980) or even decreased (Ramwell & Shaw, 1970) prostaglandin release by incubated adrenal tissue or cell suspension were observed after adding ACTH. In agreement with the latter observation, increased activity of the catabolic enzymes, prostaglandin-9-oxoreductase and prostaglandin-15-OH dehydrogenase, in response to ACTH was also reported (Levasseur, Friedman & Burke, 1980) . Experiments with prostaglandin synthetase inhibitors also resulted in conflicting data. While prostaglandin inhibitors did not reduce the effect of ACTH on glucocorticoid secretion in vivo or production in vitro (Vukosan, Kramer, Pope, Greiner & Colby, 1976; Beirne & Jubiz, 1978; Matsuoka et al. 1980) dose-dependent as well as time-dependent effects were also observed (Honn & Chavin 1976; Laychock & Rubin, 1976 ).
The role of prostaglandins in the stimulation of zona glomerulosa by ACTH has been thoroughly investigated. Honn & Chavin (1976) found that indomethacin and 7-oxa-13-prostynoic acid blocked the aldosterone-stimulating effect of ACTH on incubated diced human adrenals in the first 4 min of incubation, but the production rate of hormone did not differ from the control in the subsequent periods. In the rat, indomethacin and aspirin failed to reduce ACTH-enhanced aldosterone production by the incubated glomerulosa tissue . Similar results were obtained from glomerulosa cell suspensions by Matsuoka et al. ( 1980) . The response of adenylate cyclase activity to ACTH and PGE, in the rat glomerulosa tissue was studied by Shima et al. (1980) (1980) . In the present experiments indomethacin did not interfere with the effect of potassium, and the effect of ETY depended on the degree of stimulation. These data indicate that intra-adrenal prostaglandins do not play any essential role in the aldosterone-stimulating action of hyperkalaemia.
The enhancement of aldosterone production in response to arachidonic acid, applied in high concentration, could not be abolished by inhibitors of prostaglandin syn¬ thesis. Moreover, arachidonic acid and its antagonist, ETY, had similar effects on basal aldosterone production rate. The degree of stimulation by ACTH or potassium was similarly influenced by the agonist, arachidonic acid, and the antagonist, ETY, suggesting some common features in the mode of action of the two lipid compounds. In this context it should be recalled that arachidonic acid, ETY, 7-oxa-13-prostynoic acid, or non-steroidal antiinflammatory drugs had comparable effects on the binding of angiotensin by zona glomerulosa membrane preparations (Simpson et al. 1980) . Increased turnover of arachidonic acid in adrenal plasma membrane phospholipids is a recently revealed, cyclic AMP-independent rapid response to ACTH (Schrey & Rubin, 1980) . Arachidonic acid, unsaturated fatty acids and ETY had a similar effect on the uterine adenylate cyclase system and contractility (Vesin, Khac & Harbon, 1978) suggesting that alterations by fatty acids of membrane architecture affects the adenylate cyclase system and excitation-secretion coupling. On the basis of these observations the possibility that the published effects of prostaglandin inhibitors on the adrenal cortex were often brought about by aspecific changes in plasma membrane lipid composition cannot be ruled out.
In summary, we have demonstrated that PGE2 specifically stimulated aldosterone production by isolated rat glomerulosa cells, but that prostaglandin inhibitors failed to attenuate the aldosterone-stimulating effect of angiotensin II, ACTH and potassium ions. In view of previously reported data and the present results the importance of intra-adrenal prostaglandins in the physiological control of aldosterone secretion seems to be ques¬ tionable. Further studies are required to elucidate the biological significance of the prostaglandin sensitivity of adrenal glomerulosa cells.
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